Rheumatoid Arthritis Clinical Trials in Houston

Showing 1081-1100 of 1,660 trials

Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification

NCT02626364

This is a proof of concept, single-arm study to investigate crenolanib monotherapy in patients with recurrent/refractory glioblastoma with PDGFRA gene amplification by assessing the progression-free survival (PFS) at 6 months. Crenolanib will be given orally starting at 100 mg TID continuously until disease progression, unacceptable toxicity, or consent withdrawal.

Recurrent/Refractory Glioblastoma

Arog Pharmaceuticals, Inc.11 participantsStarted Apr 2016

Houston, Texas, United States

TERMINATEDPhase 4< 1 mile

Safety of 1 g and 2 g of Cefazolin in Pediatric Subjects

NCT03231228

This is a Phase 4, open-label, single-dose, parallel-group, multicenter, safety study of cefazolin (1 g or 2 g) in pediatric subjects between 10 and 17 years of age (inclusive) scheduled for surgery.

Postoperative Infection

B. Braun Medical Inc.61 participantsStarted Nov 2017

Little Rock, Arkansas, United States • Columbia, Missouri, United States • Dallas, Texas, United States +2 more locations

COMPLETEDNA< 1 mile

Clinical Investigation of the Next Generation Intraocular Lens

NCT03500198

An investigational IOL designed to provide improved intermediate and near visual acuity and decreased spectacle wear was evaluated for safety and effectiveness in a six-month study.

Cataract

Johnson & Johnson Surgical Vision, Inc.247 participantsStarted Jun 2018

Torrance, California, United States • Bradenton, Florida, United States • Jacksonville, Florida, United States +7 more locations

Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification

Safety of 1 g and 2 g of Cefazolin in Pediatric Subjects

Clinical Investigation of the Next Generation Intraocular Lens

Rheumatoid Arthritis Trials in Other Cities

Postoperative Respiratory Abnormalities

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Study in Participants With Acute Migraines Headaches

ACT for CP Individual Patient Expanded Access IND Protocol

Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies

Comparison Between Gastric and Post Pyloric Tube Feedings in Children With Bronchiolitis Requiring High Flow Nasal Cannula

Validation of a New Post Image Processing Engine (S-Vue™) for the Reduction of Ionizing Radiation Dose on X-ray Examination in Pediatric Patients

Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis

Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain

Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion

An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US

LEVANT 2 Safety Registry

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD

Other Conditions in Houston